Validation of an automated intact N-terminal propeptide of type I procollagen (PINP) assay

Clinical Biochemistry

Volumn 43, Issue 18, 2010, Pages 1453-1457

  Koivula, Marja Kaisa ^a   Richardson, Jill ^b   Leino, Aila ^c   Valleala, Heikki ^d   Griffiths, Katie ^b   Barnes, Alex ^b   Konttinen, Yrjö T ^d,e,f   Garrity, Martha ^b   Risteli, Juha ^a  

^a UNIVERSITY OF OULU   (Finland)

^b Immunodiagnostic Systems Ltd (IDS Ltd)   (United Kingdom)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^f COXA Hospital for Joint Replacement ^*  (Finland)

Author keywords

Automated assay; Intact PINP; Propeptide; Total PINP; Type I collagen

Indexed keywords

ANTIGEN; COLLAGEN TYPE 1; PROCOLLAGEN C PROTEINASE;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; AUTOMATION; CELL FRACTIONATION; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FEMALE; GEL FILTRATION; HEMODIALYSIS PATIENT; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; ROOM TEMPERATURE; THERMOSTABILITY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CHEMILUMINESCENT MEASUREMENTS; COLLAGEN TYPE I; HUMANS; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 78149495968     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.09.019     Document Type: Article

References (16)

1. Risteli J., Risteli L. Products of bone collagen metabolism. Chapter 2006, 23:391-405. Academic Press, London. II edition. M.J. Seibel, S.P. Robins, J.P. Bilezikian (Eds.).
2. Risteli J., Risteli L. Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects. J Hepatol 1995, 22(Suppl 2):77-81.
3. Melkko J., Kauppila S., Niemi S., Risteli L., Haukipuro K., Jukkola A., et al. Immunoassay for the intact amino-terminal propeptide of human type I procollagen. Clin Chem 1996, 42:947-954.
4. Jensen P.B., Rasmussen H.B., Pedersen F.B. Serum concentration of the aminopropeptide of type I procollagen in patients on haemo- and peritoneal dialysis. APMIS 1997, 105:371-377.
5. Rasmussen B.H., Teisner B., Bangsgaard-Petersen F., Yde-Andersen E., Kassem M. Quantification of fetal antigen 2 (FA2) in supernatants of cultured osteoblasts, normal human serum, and serum from patients with chronic renal failure. Nephrol Dial Transplant 1992, 7:902-907.
6. Koivula M.K., Ruotsalainen V., Björkman M., Nurmenniemi S., Ikäheimo R., Savolainen K., et al. Difference between total and intact assays for N-terminal propeptide of type I procollagen (PINP) reflects degradation of pN-collagen rather than denaturation of intact propeptide. Ann Clin Biochem 2010, 47:67-71.
7. Melkko J., Hellevik T., Risteli L., Risteli J., Smedsrød B. Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells. J Exp Med 1994, 179:405-412.
8. Ueda M., Inaba M., Okuno S., Nagasue K., Kitatani K., Ishimura E., et al. Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients. Am J Kidney Dis 2002, 40:802-809.
9. Alvarez L., Torregrosa J.V., Peris P., Monegal A., Bedini J.L., Martinez De Osaba M.J., et al. Effect of hemodialysis and renal failure on serum biochemical markers of bone turnover. J Bone Miner Metab 2004, 22:254-259.
10. Brandt J., Krogh T.N., Jensen C.H., Frederiksen J.K., Teisner B. Thermal instability of the trimeric structure of the N-terminal propeptide of human procollagen type I in relation to assay technology. Clin Chem 1999, 45:47-53.
11. Garnero P., Vergnaud P., Hoyle N. Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis. Clin Chem 2008, 54:188-196.
12. Marjoniemi E., Hakalahti L., Immonen M., Niemi S., Novamo A., Risteli J. Sandwich CLIAs for the variants of the aminoterminal propeptide of type I procollagen. JBMR 2001, 16:s246.
13. Clinical and Laboratory Standards Institute Protocols for determination of limits of detection and limits of quantitation, approved guideline. CLSI document EP17. Wayne, PA USA:CLSI 2004.
14. Clinical and Laboratory Standards Institute Evaluation of the Linearity of Quantitative Measurement Procedures: A Statistical Approach; Approved Guideline CLSI document EP17. Wayne, PA USA:CLSI 2003.
15. Suvanto-Luukkonen E., Risteli L., Sundström H., Penttinen J., Kauppila A., Risteli J. Comparison of three serum assays for bone collagen formation during postmenopausal estrogen-progestin therapy. Clin Chim Acta 1997, 266:105-116.
16. Kit insert. Total P1NP Elecsys and cobas® analyzers, Roche Diagnostics, Mannheim. 2006-11, page 2/4 (V 4 English).